Faecal microbiota transplantation for treatment of recurrent or refractory Clostridioides difficile infection in Hong Kong
INTRODUCTION: Clostridioides difficile infection (CDI) is a leading cause of healthcare-associated infection globally, causing significant morbidity and mortality. Faecal microbiota transplantation (FMT) has emerged as a promising option for recurrent and refractory CDI. This study aimed to assess the safety, efficacy, and feasibility of FMT for CDI in Hong Kong.
METHODS: We conducted a single-centre, retrospective study for all consecutive cases of recurrent or refractory CDI who underwent FMT from 2013 to 2018. Clinical demographics, outcome, and safety parameters were collected.
RESULTS: A total of 24 patients with recurrent or refractory CDI (median age 70 years, interquartile range=45.0-78.3 years; 67% male) were included. Over 80% had been recently hospitalised or were long-term care facility residents. Faecal microbiota transplantation was delivered by feeding tube in 11 (45.8%), oesophagogastroduodenoscopy in eight (33.3%), and colonoscopy in six (25%) of the patients. Resolution of diarrhoea without relapse within 8 weeks was achieved in 21 out of 24 patients (87.5%) after FMT. No deaths occurred within 30 days. The FMT was well tolerated and no serious adverse events attributable to FMT were reported.
CONCLUSION: Our results confirm that FMT is a safe, efficacious, and feasible intervention for patients with refractory or recurrent CDI in Hong Kong. Given the increasing disease burden and the lack of effective alternatives in Hong Kong for difficult-to-treat cases of CDI, we recommend that a territory-wide FMT service be established to address increasing demand for this treatment.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
|---|---|
| Enthalten in: |
Hong Kong medical journal = Xianggang yi xue za zhi - 25(2019), 3 vom: 09. Juni, Seite 178-182 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lui, R N [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biological specimen banks |
|---|
| Anmerkungen: |
Date Completed 08.07.2020 Date Revised 08.07.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.12809/hkmj197855 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM297955810 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM297955810 | ||
| 003 | DE-627 | ||
| 005 | 20231225093122.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.12809/hkmj197855 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0993.xml |
| 035 | |a (DE-627)NLM297955810 | ||
| 035 | |a (NLM)31178437 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lui, R N |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Faecal microbiota transplantation for treatment of recurrent or refractory Clostridioides difficile infection in Hong Kong |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.07.2020 | ||
| 500 | |a Date Revised 08.07.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a INTRODUCTION: Clostridioides difficile infection (CDI) is a leading cause of healthcare-associated infection globally, causing significant morbidity and mortality. Faecal microbiota transplantation (FMT) has emerged as a promising option for recurrent and refractory CDI. This study aimed to assess the safety, efficacy, and feasibility of FMT for CDI in Hong Kong | ||
| 520 | |a METHODS: We conducted a single-centre, retrospective study for all consecutive cases of recurrent or refractory CDI who underwent FMT from 2013 to 2018. Clinical demographics, outcome, and safety parameters were collected | ||
| 520 | |a RESULTS: A total of 24 patients with recurrent or refractory CDI (median age 70 years, interquartile range=45.0-78.3 years; 67% male) were included. Over 80% had been recently hospitalised or were long-term care facility residents. Faecal microbiota transplantation was delivered by feeding tube in 11 (45.8%), oesophagogastroduodenoscopy in eight (33.3%), and colonoscopy in six (25%) of the patients. Resolution of diarrhoea without relapse within 8 weeks was achieved in 21 out of 24 patients (87.5%) after FMT. No deaths occurred within 30 days. The FMT was well tolerated and no serious adverse events attributable to FMT were reported | ||
| 520 | |a CONCLUSION: Our results confirm that FMT is a safe, efficacious, and feasible intervention for patients with refractory or recurrent CDI in Hong Kong. Given the increasing disease burden and the lack of effective alternatives in Hong Kong for difficult-to-treat cases of CDI, we recommend that a territory-wide FMT service be established to address increasing demand for this treatment | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Biological specimen banks | |
| 650 | 4 | |a Clostridium difficile | |
| 650 | 4 | |a Fecal microbiota transplantation | |
| 700 | 1 | |a Wong, S H |e verfasserin |4 aut | |
| 700 | 1 | |a Lau, L H S |e verfasserin |4 aut | |
| 700 | 1 | |a Chan, T T |e verfasserin |4 aut | |
| 700 | 1 | |a Cheung, K C Y |e verfasserin |4 aut | |
| 700 | 1 | |a Li, A |e verfasserin |4 aut | |
| 700 | 1 | |a Chin, M L |e verfasserin |4 aut | |
| 700 | 1 | |a Tang, W |e verfasserin |4 aut | |
| 700 | 1 | |a Ching, J Y L |e verfasserin |4 aut | |
| 700 | 1 | |a Lam, K L Y |e verfasserin |4 aut | |
| 700 | 1 | |a Chan, P K S |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, J C Y |e verfasserin |4 aut | |
| 700 | 1 | |a Sung, J J Y |e verfasserin |4 aut | |
| 700 | 1 | |a Chan, F K L |e verfasserin |4 aut | |
| 700 | 1 | |a Ng, S C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Hong Kong medical journal = Xianggang yi xue za zhi |d 1997 |g 25(2019), 3 vom: 09. Juni, Seite 178-182 |w (DE-627)NLM094541337 |x 1024-2708 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2019 |g number:3 |g day:09 |g month:06 |g pages:178-182 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.12809/hkmj197855 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2019 |e 3 |b 09 |c 06 |h 178-182 | ||